Literature DB >> 12141830

Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Gerond Lake-Bakaar1, Vito Mazzoccoli, Lynda Ruffini.   

Abstract

Viral dynamic studies in chronic hepatitis C virus (HCV) infection indicate a significantly shortened survival of virus-infected cells. Since at the steady state of chronic viral infection, the rate of infected cell elimination equals new cell regeneration, this would imply a high rate of hepatocyte turnover in chronic HCV liver disease. We estimated the fraction of regenerating hepatocytes in liver biopsy sections in chronic HCV liver disease, cirrhosis, and hepatocellular carcinoma (HCC). We used antibodies to proliferating cell nuclear antigen (PCNA) to detect proliferating cell nuclei in liver biopsy specimen from controls and patients with chronic hepatitis, cirrhosis, and HCC. We also used bis-benzimide to label fluorescently all hepatocyte nuclei simultaneously. Using digital image analysis, we calculated the area occupied by PCNA-stained hepatocyte nuclei, as a fraction of the total area occupied by fluorescently labeled hepatocyte nuclei (labeling index; LI). Antibody staining was negligible in the control specimen. The mean +/- SE PCNA LI increased from 0.21 +/- 0.1 in chronic hepatitis to 0.63 +/- 0.15 in HCC. There was no significant difference between chronic hepatitis and cirrhosis. The fraction of cells undergoing regeneration is increased in chronic HCV liver disease, HCV-related cirrhosis, and HCC. Increased hepatocyte turnover could provide the link between chronic HCV liver disease and HCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12141830     DOI: 10.1023/a:1015800126283

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.

Authors:  K L Rudolph; S Chang; M Millard; N Schreiber-Agus; R A DePinho
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

2.  Telomere length in human liver diseases.

Authors:  Y Urabe; K Nouso; T Higashi; H Nakatsukasa; N Hino; K Ashida; N Kinugasa; K Yoshida; S Uematsu; T Tsuji
Journal:  Liver       Date:  1996-10

Review 3.  Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma.

Authors:  M Colombo
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

4.  Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.

Authors:  N Miura; I Horikawa; A Nishimoto; H Ohmura; H Ito; S Hirohashi; J W Shay; M Oshimura
Journal:  Cancer Genet Cytogenet       Date:  1997-01

5.  Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.

Authors:  F Farinati; R Cardin; A D'Errico; N De Maria; R Naccarato; A Cecchetto; W Grigioni
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

6.  Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.

Authors:  H Kojima; O Yokosuka; F Imazeki; H Saisho; M Omata
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

7.  Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.

Authors:  Y Edamoto; M Tani; T Kurata; K Abe
Journal:  Cancer       Date:  1996-05-01       Impact factor: 6.860

8.  Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area.

Authors:  H S Lee; C J Han; C Y Kim
Journal:  Cancer       Date:  1993-11-01       Impact factor: 6.860

9.  Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis.

Authors:  M Delhaye; H Louis; C Degraef; O Le Moine; J Devière; B Gulbis; D Jacobovitz; M Adler; P Galand
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

10.  Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.

Authors:  S Zeuzem; J M Schmidt; J H Lee; M von Wagner; G Teuber; W K Roth
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

View more
  6 in total

1.  Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.

Authors:  Azza E El Bassiouny; Mona M Nosseir; Mona K Zoheiry; Noha A Ameen; Ahmed M Abdel-Hadi; Ibrahim M Ibrahim; Suher Zada; Abdel-Hakeem Saad El-Deen; Nora E El-Bassiouni
Journal:  World J Hepatol       Date:  2010-01-27

2.  Effect of ribavirin and amantadine on early hepatitis C virus RNA rebound and clearance in serum during daily high-dose interferon.

Authors:  Gerond Lake-Bakaar; Lynda Ruffini; Petr Kuzmic
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

4.  Modulations of cell cycle checkpoints during HCV associated disease.

Authors:  Saira Sarfraz; Saeed Hamid; Syed Ali; Wasim Jafri; Anwar A Siddiqui
Journal:  BMC Infect Dis       Date:  2009-08-10       Impact factor: 3.090

Review 5.  Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis.

Authors:  Nikolaos P Karidis; Ioanna Delladetsima; Stamatios Theocharis
Journal:  Gastroenterol Res Pract       Date:  2015-03-29       Impact factor: 2.260

6.  Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection.

Authors:  Saira Sarfraz; Saeed Hamid; Anwar Siddiqui; Snawar Hussain; Shahid Pervez; Graeme Alexander
Journal:  BMC Microbiol       Date:  2008-08-05       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.